Da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics (MLTX), sold 47,775 shares at $20.03 ($957K) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Scheduled sale ($957k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MLTX | SELL | 2025-12-10 | $3.0M | — | Filing → |
| MLTX | SELL | 2024-02-29 | $7.1M | — | Filing → |
| MLTX | SELL | 2024-02-23 | $124K | — | Filing → |